Classifying and treating physiologic brain imbalances using quantitative EEG: Key Neurotech Patent #15


– Illus­tra­tive image from U.S. Patent No. 6,622,036

Today we are shar­ing a 2003 patent assigned to CNS Response, Inc. (As men­tioned, we are fea­tur­ing a foun­da­tion­al Per­va­sive Neu­rotech patent a day, from old­er to new­er by issue date)

U.S. Patent No. 6,622,036: Method for clas­si­fy­ing and treat­ing phys­i­o­log­ic brain imbal­ances using quan­ti­ta­tive EEG.

  • Assignee(s): CNS Response, Inc
  • Inventor(s): Stephen Suffin
  • Tech­nol­o­gy Cat­e­go­ry: EEG
  • Issue Date: Sep­tem­ber 16, 2003

SharpBrains’ Take:

The ‘036 patent dis­clos­es the appli­ca­tion of quan­ti­fied EEG to brain imbal­ances (e.g., phys­i­o­log­i­cal imbal­ances). The val­ue deliv­ered by using an EEG device entire­ly depends on the abil­i­ty to under­stand sig­nals gen­er­at­ed by the EEG device. Quan­ti­ta­tive analy­sis of these sig­nals has become a crit­i­cal aspect in EEG sig­nal pro­cess­ing. The claims of the 036′ patent explic­it­ly exclude cov­er­age of psy­chi­atric diag­noses, poten­tial­ly pre­sent­ing either an easy-design around or infringe­ment defense argu­ment. How­ev­er, the ‘036 patent oth­er­wise appears to have extreme­ly broad claim cov­er­age of quan­ti­ta­tive assess­ments for med­ica­tion treat­ments — one of the pri­ma­ry fac­tors mak­ing it a key non-inva­sive neu­rotech­nol­o­gy patent.


Neu­ro­phys­i­o­log­ic infor­ma­tion such as quan­ti­ta­tive elec­troen­cephalog­ra­phy (QEEG) is used in a method for clas­si­fy­ing, diag­nos­ing, and treat­ing phys­i­o­log­ic brain imbal­ances. Neu­ro­phys­i­o­log­ic infor­ma­tion is also used to guide sam­ple selec­tion in clin­i­cal tests for psy­chophar­ma­co­log­ic drug can­di­dates. Final­ly, neu­ro­phys­i­o­log­ic infor­ma­tion is used for remote­ly assess­ing and treat­ing patients with phys­i­o­log­ic brain imbalances.

Illus­tra­tive Claim 1. A method for treat­ing phys­i­o­log­ic brain imbal­ances, com­pris­ing: obtain­ing neu­ro­phys­i­o­log­ic infor­ma­tion from a patient, quan­ti­fy­ing the neu­ro­phys­i­o­log­ic infor­ma­tion, and cor­re­lat­ing the quan­ti­fied neu­ro­phys­i­o­log­ic infor­ma­tion to med­ica­tion ther­a­py respon­siv­i­ty pro­files, with­out regard to psy­chi­atric diag­nos­tic category.

To learn more about mar­ket data, trends and lead­ing com­pa­nies in the dig­i­tal brain health space –dig­i­tal plat­forms for brain/ cog­ni­tive assess­ment, mon­i­tor­ing and enhance­ment– check out this mar­ket report. To learn more about our analy­sis of 10,000+ patent fil­ings, check out this IP & inno­va­tion neu­rotech report.

About SharpBrains

SHARPBRAINS is an independent think-tank and consulting firm providing services at the frontier of applied neuroscience, health, leadership and innovation.
SHARPBRAINS es un think-tank y consultoría independiente proporcionando servicios para la neurociencia aplicada, salud, liderazgo e innovación.

Top Articles on Brain Health and Neuroplasticity

Top 10 Brain Teasers and Illusions


Subscribe to our e-newsletter

* indicates required

Got the book?